JP2025511108A5 - - Google Patents

Info

Publication number
JP2025511108A5
JP2025511108A5 JP2024557888A JP2024557888A JP2025511108A5 JP 2025511108 A5 JP2025511108 A5 JP 2025511108A5 JP 2024557888 A JP2024557888 A JP 2024557888A JP 2024557888 A JP2024557888 A JP 2024557888A JP 2025511108 A5 JP2025511108 A5 JP 2025511108A5
Authority
JP
Japan
Prior art keywords
polypeptide
fusion protein
amino acid
nucleic acid
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024557888A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025511108A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/058572 external-priority patent/WO2023187201A1/en
Publication of JP2025511108A publication Critical patent/JP2025511108A/ja
Publication of JP2025511108A5 publication Critical patent/JP2025511108A5/ja
Pending legal-status Critical Current

Links

JP2024557888A 2022-04-01 2023-03-31 トロンボポエチン受容体フラグメントおよびそれらの使用 Pending JP2025511108A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22166302.4 2022-04-01
EP22166302 2022-04-01
PCT/EP2023/058572 WO2023187201A1 (en) 2022-04-01 2023-03-31 Thrombopoietin receptor fragments and uses thereof

Publications (2)

Publication Number Publication Date
JP2025511108A JP2025511108A (ja) 2025-04-15
JP2025511108A5 true JP2025511108A5 (cg-RX-API-DMAC7.html) 2026-04-03

Family

ID=81580134

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024557888A Pending JP2025511108A (ja) 2022-04-01 2023-03-31 トロンボポエチン受容体フラグメントおよびそれらの使用

Country Status (6)

Country Link
US (1) US20250250320A1 (cg-RX-API-DMAC7.html)
EP (1) EP4504770A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025511108A (cg-RX-API-DMAC7.html)
AU (1) AU2023244526A1 (cg-RX-API-DMAC7.html)
CA (1) CA3246911A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023187201A1 (cg-RX-API-DMAC7.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1230368A2 (en) * 1999-11-18 2002-08-14 Schering Corporation Mammalian receptor proteins; related reagents and methods

Similar Documents

Publication Publication Date Title
JP2023504914A5 (cg-RX-API-DMAC7.html)
JP7385680B2 (ja) 変異型ｒｓｖ ｆタンパク質及びその利用
US9757450B2 (en) Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof
US20250163108A1 (en) Self-assembling protein nanoparticles with built-in six-helix bundle proteins
JP2021527077A5 (cg-RX-API-DMAC7.html)
JP2020515280A5 (cg-RX-API-DMAC7.html)
JP2023505492A5 (cg-RX-API-DMAC7.html)
FI3606942T3 (fi) Itsejärjestyviä proteiininanorakenteita, jotka esittävät paramyksovirus- ja/tai pneumovirus f -proteiineja ja niiden käyttö
FI2970398T3 (fi) Rsv f -prefuusioproteiineja ja niiden käyttö
JP2015509707A5 (cg-RX-API-DMAC7.html)
JP2023553697A5 (cg-RX-API-DMAC7.html)
JP2023513592A5 (cg-RX-API-DMAC7.html)
PL363071A1 (pl) Sposoby i kompozycje dla zmniejszenia replikacji HIV-1
JP2023554379A5 (cg-RX-API-DMAC7.html)
JP2023542297A5 (cg-RX-API-DMAC7.html)
JP2022544053A5 (cg-RX-API-DMAC7.html)
JP2023522154A5 (cg-RX-API-DMAC7.html)
WO2023246853A1 (zh) 抗新型冠状病毒人源化多价结合蛋白及其应用
WO2023009028A1 (ru) Однодоменное антитело и его модификации, специфически связывающиеся с rbd s белка вируса sars-cov-2
CN103755810B (zh) 一种长效hiv‐1膜融合抑制剂
JP2018516247A5 (cg-RX-API-DMAC7.html)
JP2019518713A5 (cg-RX-API-DMAC7.html)
JP2025511108A5 (cg-RX-API-DMAC7.html)
WO2023143445A1 (zh) 用于治疗hbv感染及相关疾病的表位肽及抗体
US12600764B2 (en) Antigen-binding proteins targeting coronavirus (COV) variants